Prognostic Significance of Expression Patterns of EGFR Family, p21 and p27 in High-grade Astrocytoma

アクセス数 : 1239
ダウンロード数 : 183

今月のアクセス数 : 3
今月のダウンロード数 : 0
ファイル情報(添付)
HiroshimaJMedSci_59_65.pdf 1.72 MB 種類 : 全文
タイトル ( eng )
Prognostic Significance of Expression Patterns of EGFR Family, p21 and p27 in High-grade Astrocytoma
作成者
Nabika Shinya
Kiya Katsuzo
Satoh Hideki
Mizoue Tatsuya
Kondo Hiroshi
Katagiri Masaya
Nishisaka Takashi
収録物名
Hiroshima Journal of Medical Sciences
59
4
開始ページ 65
終了ページ 70
収録物識別子
[PISSN] 0018-2052
[EISSN] 2433-7668
[NCID] AA00664312
抄録
The goal of this study was to investigate the relationship among immunohistochemical expression of epithelial growth factor receptor (EGFR) family proteins, p21, p27 and prognosis in patients with high-grade astrocytoma. Expression of EGFR family proteins (c-erbB-1, c-erbB-2, c-erbB-3, c-erbB-4), p21 and p27 and Ki-67 labeling index (LI) were studied in 59 samples of high-grade astrocytoma. Expression of protein levels was analyzed by immunohistochemical staining of formalin-fixed and paraffin-embedded sections. Results were analyzed in relation to age, gender and survival. Overexpression of c-erbB-1, c-erbB-2, c-erbB-3 and c-erbB-4 was found in 40 (67.8%), 17 (28.8%), 3 (5.1 %) and 42 (75.0%) samples, respectively. Similarly, low expression of p21 and p27 was observed in 50 (84.8%) and 27 (45.8%) samples. Mean Ki-67 LI was 17.3 ± 1.1. Cox multiple regression analysis showed that c-erbB-1 (Hazard rate(HR) 1.57, 95% Confidence interval (Cl) 1.08-2.36; p=0.017), c-erbB-4 (HR 1.79, 95%CI 1.20- 2. 7 4; p=0.004) and p27 (HR 0.50, 95%CI 0.30-0.82; p=0.006) were significantly associated with survival. High expression of c-erbB-1 and c-erbB-4 and low expression of p27 were associated with poor prognosis in these patients.
著者キーワード
EGFR
p27
p21
High-grade astrocytoma
NDC分類
医学 [ 490 ]
言語
英語
資源タイプ 紀要論文
出版者
Hiroshima University Medical Press
発行日 2010-12
権利情報
(c) Hiroshima University Medical Press.
出版タイプ Version of Record(出版社版。早期公開を含む)
アクセス権 オープンアクセス
収録物識別子
[ISSN] 0018-2052
[NCID] AA00664312